Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:9676
SEHK:9676Food

Asian Value Opportunities: 3 Stocks Estimated Below Intrinsic Value In January 2026

As 2026 begins, Asian markets are capturing investor attention with strong performances, particularly in China and Japan, where indices have shown notable gains amid optimism about the domestic tech sector and consumer spending. In this environment of growth and potential policy shifts, identifying stocks that are estimated to be trading below their intrinsic value can present compelling opportunities for investors seeking to capitalize on undervalued assets in a thriving market.
SZSE:300133
SZSE:300133Entertainment

Asian Growth Companies With Strong Insider Ownership

As the Asian markets continue to show resilience amid global economic fluctuations, investors are increasingly drawn to companies with strong growth prospects and significant insider ownership. In this context, stocks that combine robust internal confidence with strategic market positioning are particularly compelling for those seeking potential opportunities in a complex financial landscape.
SZSE:002005
SZSE:002005Consumer Durables

3 Asian Penny Stocks With Market Caps Under US$800M

As global markets navigate a complex landscape marked by geopolitical tensions and economic shifts, Asian equities have shown resilience, with particular strength in small-cap and value shares. For investors exploring opportunities beyond the traditional large-cap stocks, penny stocks—despite their seemingly outdated name—remain a compelling area of interest due to their potential for significant returns when backed by solid financials. In this article, we explore three Asian penny stocks...
TWSE:6670
TWSE:6670Leisure

Asian Dividend Stocks To Consider For Your Portfolio

As global markets navigate geopolitical tensions and economic shifts, Asian indices have shown resilience, with Chinese stocks gaining momentum fueled by optimism in the domestic tech sector. In this dynamic environment, dividend stocks can offer a blend of income and potential stability for investors seeking to diversify their portfolios amidst fluctuating market conditions.
NYSE:APAM
NYSE:APAMCapital Markets

A US$2.7 Billion Pension Redemption Might Change The Case For Investing In Artisan (APAM)

Artisan Partners Asset Management reported preliminary assets under management of US$180.80 billion as of November 30, 2025, and disclosed that annual fund distributions and a US$2.70 billion redemption by a non‑U.S. institutional client in early December affected these figures. This combination of income and capital gains distributions with a large, pension‑linked institutional outflow highlights how client concentration and market structure can quickly reshape Artisan’s asset base. We’ll...
ENXTAM:ALLFG
ENXTAM:ALLFGCapital Markets

Assessing Allfunds Group (ENXTAM:ALLFG) Valuation After New Apex Partnership Expands Offshore Access

Apex Fintech Solutions has agreed to integrate Allfunds Group (ENXTAM:ALLFG) into its AscendOS platform, giving U.S. offshore and international firms easier access to offshore mutual funds, ETFs, and alternative investments. See our latest analysis for Allfunds Group. The Apex announcement comes after a period where momentum has picked up, with a 90 day share price return of 22.49% and a 1 year total shareholder return of 71.37%, even though the year to date share price return is slightly...
NasdaqCM:SIFY
NasdaqCM:SIFYTelecom

Sify Technologies (NasdaqCM:SIFY) Q3 Loss Tests Bullish Margin Improvement Narratives

Sify Technologies (NasdaqCM:SIFY) has just posted its Q3 2026 numbers, with revenue of ₹11,596 million and a net loss, excluding extra items, of ₹329 million, setting the tone for how investors assess its current footing. The company has seen quarterly revenue move from ₹10,491 million in Q3 2025 to ₹11,596 million in Q3 2026, while trailing 12 month revenue stands at ₹42,550.58 million against a trailing 12 month net loss of ₹1,569.96 million, which keeps the spotlight firmly on its margin...
NYSEAM:NBY
NYSEAM:NBYPharmaceuticals

Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales

In recent days NovaBay Pharmaceuticals has attracted intense trading interest as it pursued asset sales, preferred stock designations, and leadership changes instead of outright liquidation, while working to maintain its NYSE American listing. This combination of corporate restructuring steps and renewed focus on preserving the public listing has turned the company into a speculative focal point for investors reviewing its remaining options. We’ll now examine how this shift toward...